---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-043305"
form_type: "8-K"
ticker: "GRAL"
cik: "0001699031"
company_name: "GRAIL, Inc."
filed_at: "2024-10-22T23:59:59+00:00"
generated_at: "2026-05-30T11:41:32.881004+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# GRAIL appoints Sarah Krevans to Board of Directors, effective Oct 21

## Summary
- Krevans appointed as Class II director; will serve on Audit, Compensation, and Nominating & Governance Committees.
- Receives annual cash retainer of $50,000 plus committee retainers ($10k Audit, $7.5k Comp, $5k NCG), and initial grant of 31,055 RSUs vesting over 3 years.
- Krevans previously President and CEO of Sutter Health; Board now has 5 directors, 4 independent.
- Company disclosed ~$1.6M in 2023 payments to Sutter Institute for Medical Research for PATHFINDER 2 study.

## SEC filing metadata
- accession: 0001628280-24-043305
- form_type: 8-K
- ticker: GRAL
- cik: 0001699031
- company_name: GRAIL, Inc.
- filed_at: 2024-10-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1699031/000162828024043305/0001628280-24-043305-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1699031/000162828024043305/gral-20241021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-043305
- JSON: https://secwatch.observer/filing/0001628280-24-043305.json
- Plain text: https://secwatch.observer/filing/0001628280-24-043305.txt

## Source-grounded claims
- claim_id: f7d7c5d240
  claim: Sarah Krevans was appointed as Director at GRAIL, Inc..
  evidence_excerpt: On October 21, 2024, the Board of Directors (the “Board”) of GRAIL, Inc. (the “Company”) appointed Sarah Krevans to the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1699031/000162828024043305/0001628280-24-043305-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.